ENvue Medical Inc
FEED
4 hedge funds and large institutions have $67.5K invested in ENvue Medical Inc in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 6 closing their positions.
0.16% more ownership
Funds ownership: 0.09% → 0.25% (+0.16%)
50% less funds holding
Funds holding: 8 → 4 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
69% less capital invested
Capital invested by funds: $215K → $67.5K (-$148K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$62.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.47K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.16K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$46 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$112K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$25.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.4K |
| 5 |
VF
Virtu Financial
New York
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $46.4K | +$62.5K | +1,362 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $17.6K | +$6.47K | +141 | +38% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3.46K | +$2.16K | +47 | +85% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $24 | +$46 | +1 | New |
|
|
AC
5
Armistice Capital
New York
| – | -$112K | -1,721 | Closed |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$25.9K | -397 | Closed |
|
|
7
Vanguard Group
Malvern,
Pennsylvania
| – | -$17.9K | -274 | Closed |
|
|
8
Geode Capital Management
Boston,
Massachusetts
| – | -$13.4K | -205 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$12K | -176 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$6.5K | -100 | Closed |
|
FEED Hedge Fund Activity: Q1 2025 in Review
4 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q1 2025, worth a combined $67.5K — down 69% from $215K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FEED and 2 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $62.5K. The largest seller was Armistice Capital, exiting entirely with an estimated $112K sold.
- 4 institutional investors held ENvue Medical Inc (FEED) as of Q1 2025, down from 8 in Q4 2024.
- Funds reported $67.5K of ENvue Medical Inc stock for Q1 2025, down 69% quarter-over-quarter.
- 2 funds opened new ENvue Medical Inc positions in Q1 2025 and 6 closed out, a net change of -4 holders.
- The largest ENvue Medical Inc buyer in Q1 2025 was Morgan Stanley, an estimated $62.5K added.
- The largest ENvue Medical Inc seller in Q1 2025 was Armistice Capital, an estimated $112K sold.
Based on aggregated 13F filings for Q1 2025.